Jeffrey S McCombs
Overview
Explore the profile of Jeffrey S McCombs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
439
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng H, McCombs J, Barzi A
Cancer Treat Res Commun
. 2022 Aug;
32:100624.
PMID: 36027699
Purpose: To explore the real-world utilization of computerized tomography (CT) in patients with advanced colorectal cancer (CRC) and the associated outcomes. Methods: Using Optum's de-identified Clinformatics® Data Mart Database (2008-2016),...
2.
Matsuda T, McCombs J, Tonnu-Mihara I, McGinnis J, Fox D
Forum Health Econ Policy
. 2019 Aug;
19(2):333-351.
PMID: 31419897
Background: The high cost of new hepatitis C (HCV) treatments has resulted in "watchful waiting" strategies being developed to safely delay treatment, which will in turn delay viral load suppression...
3.
Jiang Y, McCombs J, Park S
CNS Drugs
. 2017 Mar;
31(4):319-326.
PMID: 28290080
Background: A recent large database analysis raised concerns of potential acute kidney injury (AKI) risk associated with antipsychotics. However, whether individual atypical and typical antipsychotics are associated with differential AKI...
4.
Fox D, McGinnis J, Tonnu-Mihara I, McCombs J
J Gastroenterol Hepatol
. 2016 Nov;
32(6):1136-1142.
PMID: 27869323
Background And Aims: Data addressing real world effectiveness of direct acting antiviral agents in hepatitis C infected patients are now emerging. This study compared the sustained virologic response rates achieved...
5.
6.
Thomas K, Jiang Y, McCombs J
Ann Clin Psychiatry
. 2015 Feb;
27(2):90-9.
PMID: 25696785
Background: Our purpose was to evaluate health care use and cost patterns for clozapine compared with olanzapine in the treatment of schizophrenia. Methods: Health care outcomes were measured over a...
7.
Shin J, McCombs J, Sanchez R, Udall M, Deminski M, Cheetham T
Am J Manag Care
. 2012 Aug;
18(8):426-34.
PMID: 22928758
Objectives: To measure primary nonadherence (PNA) rates for 10 therapeutic drug groups and identify factors associated with PNA to chronic and acute medications. Study Design: Retrospective cohort study. Methods: New...
8.
Rashid N, McCombs J, Schwartz E
Clin Ther
. 2012 Apr;
34(5):1145-58.
PMID: 22464691
Objective: We compared health care costs and medication persistence for patients with type 2 diabetes initiating treatment using exenatide, pen insulin, or vial insulin. Methods: Commercial health plan data (2004-2008)...
9.
McCombs J, Yuan Y, Shin J, Saab S
Clin Ther
. 2011 Aug;
33(9):1268-80.
PMID: 21840056
Background: New therapies for Hepatitis C virus (HCV) are under development that will augment pegylated interferon-alpha plus ribavirin to improve patient outcomes. Data documenting the incremental economic and health burden...
10.
The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system
Shin J, Cheetham T, Wong L, Niu F, Kass E, Yoshinaga M, et al.
J Am Acad Dermatol
. 2011 May;
65(6):1117-25.
PMID: 21565419
Background: Preventing fetal exposure to isotretinoin is widely acknowledged as an important safety issue. The iPLEDGE program is the latest in a series of Food and Drug Administration-mandated risk management...